Barclays PLC Abb Vie Inc. Put Options Transaction History

Barclays PLC

$327 Billion
Q2 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $26.3 Million - $29.9 Million	-164,400 Reduced 44.36%	206,200 $37.5 Million
Q4 2023 Feb 15, 2024	BUY	$137.6 - $154.97 $51 Million - $57.4 Million	370,600 New	370,600 $57.4 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $20.8 Million - $23.9 Million	143,600 Added 51.43%	422,800 $67.4 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $10.3 Million - $11.8 Million	76,400 Added 37.67%	279,200 $37.5 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $5.12 Million - $6.51 Million	37,200 Added 22.46%	202,800 $31.1 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $18.2 Million - $22.6 Million	137,900 Added 497.83%	165,600 $26.8 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $2.15 Million - $2.72 Million	-20,000 Reduced 41.93%	27,700 $3.75 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $41.2 Million - $46.7 Million	-386,800 Reduced 89.02%	47,700 $5.15 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $45.5 Million - $50.6 Million	432,000 Added 17280.0%	434,500 $48.9 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $139 Million - $153 Million	-1,360,228 Reduced 99.82%	2,500 $271,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $36.2 Million - $48.9 Million	450,000 Added 49.3%	1,362,728 $146 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $1.2 Million - $1.41 Million	-13,974 Reduced 1.51%	912,728 $79.9 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $10.2 Million - $13.7 Million	-139,098 Reduced 13.05%	926,702 $91 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $28.9 Million - $43.8 Million	447,800 Added 72.46%	1,065,800 $81.2 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $14.1 Million - $17.6 Million	195,000 Added 46.1%	618,000 $54.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $7.87 Million - $9.47 Million	-125,000 Reduced 22.81%	423,000 $32 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $19.7 Million - $25.2 Million	300,200 Added 121.15%	548,000 $39.9 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $3.8 Million - $4.48 Million	-49,300 Reduced 16.59%	247,800 $20 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $801,854 - $988,903	-10,300 Reduced 3.35%	297,100 $27.4 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $6.46 Million - $7.19 Million	-72,700 Reduced 19.13%	307,400 $29.1 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $260,362 - $308,067	2,900 Added 0.77%	380,100 $35.2 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $11.5 Million - $15.4 Million	124,800 Added 49.45%	377,200 $35.7 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $10.6 Million - $11.6 Million	118,100 Added 87.94%	252,400 $24.4 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $9.38 Million - $12 Million	134,300	134,300 $11.9 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$34.2 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$27.4 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.6 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$10.4 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.74 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account